Jenal U: Pseudomonas aeruginosa breaches respiratory epithelia

Rybniker J: Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa

Clardy J: Mining of the human microbiome for antimicrobial peptide discovery

Didierlaurent A: New vaccine technologies for immunocompromised populations

Maertens K: Prevention by vaccination in pregnant women

Moline H: Pediatric RSV Epidemiology and New Prevention Product Use in the U.S.

Arts R. J. W.: Trained immunity and its role in health and disease

Pittet L: Trained immunity in practice: BCG and risk of infectious diseases

Bargetzi A: Bizarre illness: Fever with unfolding hepatitis

Weller D: Traces obscuring the vision

Sia-Herren C: Insidious back pain and scrotal swelling

Brahier Th: Another bizzare case from Lausanne

L'Huilier A: Increasing immunosuppression: will it save or kill my patient?

Kirchhoff F: Virus-guided CRISPR/Cas9 screens identify novel antiviral factors and mechanisms

Paiardini M: Leveraging the SIV Model to Assess Immunotherapy-Based Cure Interventions

Finzi A: Exploiting HIV-1 Env conformation for clinical intervention

Koopmans M: One Health, climate change and emerging viruses

Greub G: Tick-borne infections: recent discoveries and future research opportunities
Harris E: Friend and Foe: Explaining the complex epidemiology and epidemiology of dengue and Zika viruses

Kontarakis Z: Primer

Herrera Carrillo E: CRISPR-based HIV cure strategies

Lei Qi St: Precision CRISPR tools for SARS-CoV-2 and broad-spectrum respiratory RNA virus targeting

Eckerle I: Emerging zoonotic viruses - what’s next?

Hilty M: One-health approach to investigate AMR dissemination

Jenal U: Pseudomonas aeruginosa breaches respiratory epithelia

Rybniker J: Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa

Clardy J: Mining of the human microbiome for antimicrobial peptide discovery

Didierlaurent A: New vaccine technologies for immunocompromised populations

Maertens K: Prevention by vaccination in pregnant women

Moline H: Pediatric RSV Epidemiology and New Prevention Product Use in the U.S.

Arts R. J. W.: Trained immunity and its role in health and disease

Pittet L: Trained immunity in practice: BCG and risk of infectious diseases

Bargetzi A: Bizarre illness: Fever with unfolding hepatitis

Weller D: Traces obscuring the vision

Sia-Herren C: Insidious back pain and scrotal swelling

Brahier Th: Another bizzare case from Lausanne

L'Huilier A: Increasing immunosuppression: will it save or kill my patient?

Kirchhoff F: Virus-guided CRISPR/Cas9 screens identify novel antiviral factors and mechanisms

Paiardini M: Leveraging the SIV Model to Assess Immunotherapy-Based Cure Interventions

Finzi A: Exploiting HIV-1 Env conformation for clinical intervention

Koopmans M: One Health, climate change and emerging viruses

Greub G: Tick-borne infections: recent discoveries and future research

opportunities
Harris E.: Friend and Foe: Explaining the complex epidemiology and epidemiology of dengue and Zika viruses

Kontarakis Z: Primer

Herrera Carrillo E: CRISPR-based HIV cure strategies

Lei Qi St: Precision CRISPR tools for SARS-CoV-2 and broad-spectrum respiratory RNA virus targeting

Eckerle I: Emerging zoonotic viruses - what’s next?

Hilty M: One-health approach to investigate AMR dissemination

Sereti I., Immune activation in people with HIV

Perreau M., The role of lymph node dendritic cells in HIV persistence

Brander Ch., Therapeutic HIV vaccination

Lecuit M., How Listeria outsmarts the host

Hardt W. D., Pathophysiology of Salmonella infections - Food, inflammasomes, persistence, resistance

Dawson L., Novel targets for development of therapeutics to combat

Clostridiodes difficile

Kanekiyo M., Structural Vaccinology for Influenza

Webby R. J., Recent spread and evolution of A(H5N1) influenza viruses

Ludwig St., Towards a novel host-targeted anti-infective strategy against COVID-19 and other acute respiratory viral diseases

Urwyler P., Difficult to swallow - easy to digest?

Weller D., Riddles in Rigidity - Neurological deterioration after HSCT

Schöbi N., Big holes in a tiny baby

Vingerhoets S., Confused by confusion

Vetter P., Brain-storm

Gagneux St, Epidemiology, Ecology and Evolution of Multidrug-resistant Tuberculosis

Van Crevel R., Host-pathogen interaction and immunotherapy in mycobacterial infections

Diacon A., Novel drugs for MDR TB treatment

Consiglio C. Deciphering sex differences in human immunity using systems immunology

Ingersoll M., Investigating mucosal immunity in the bladder

Terrier O., Respiratory co-infections: when the whole is greater than the sum

Soldati-Favre D., Parasite manipulation of predator fear

Bogdan Ch., Immunopathogenesis and novel treatment approaches

of cutaneous leishmaniasis

Chappuis F., Visceral leishmaniasis: epidemiological and clinical aspects

Sereti I., Immune activation in people with HIV

Perreau M., The role of lymph node dendritic cells in HIV persistence

Brander Ch., Therapeutic HIV vaccination

Lecuit M., How Listeria outsmarts the host - slides not available

Hardt W. D., Pathophysiology of Salmonella infections - Food, inflammasomes, persistence, resistance

Dawson L., Novel targets for development of therapeutics to combat

Clostridiodes difficile

Kanekiyo M., Structural Vaccinology for Influenza

Webby R. J., Recent spread and evolution of A(H5N1) influenza viruses

Ludwig St., Towards a novel host-targeted anti-infective strategy against COVID-19 and other acute respiratory viral diseases

Urwyler P., Difficult to swallow - easy to digest?

Weller D., Riddles in Rigidity - Neurological deterioration after HSCT

Schöbi N., Big holes in a tiny baby

Vingerhoets S., Confused by confusion

Vetter P., Brain-storm

Gagneux St,, Epidemiology, Ecology and Evolution of Multidrug-resistant Tuberculosis

Gagneux St., webcast replies to audience questions

Van Crevel R., Host-pathogen interaction and immunotherapy in mycobacterial infections

Diacon A., Novel drugs for MDR TB treatment

Consiglio C. Deciphering sex differences in human immunity using systems immunology - slides not available

Ingersoll M., Investigating mucosal immunity in the bladder

Terrier O., Respiratory co-infections: when the whole is greater than the sum - slides not available

Soldati-Favre D., Parasite manipulation of predator fear

Bogdan Ch., Immunopathogenesis and novel treatment approaches

of cutaneous leishmaniasis - slides not available

Chappuis F., Visceral leishmaniasis: epidemiological and clinical aspects

Hensley S. E., Multivalent mRNA-based influenza vaccines

Miller M. S., Respiratory mucosal delivery of next-generation COVID-19 vaccines

Karron R. A., Progress in RSV vaccines

Stocker R., Combining single-cell imaging and artificial intelligence for Antibiotic Susceptibility Testing in 90 minutes

Kline K., Colonization, biofilm formation and virulence in Enterococcus faecalis

Henriques Normark B., Host-pathogen interaction in Streptococcus pneumoniae infections

Miro J. M., Novel therapies of endocarditis

Burgener A.-V., Septic shock with severe thrombocytopenia in a pregnant woman 

Ihle V., A case of disseminated nocardiosis after checkpoint inhibition

Colin-Benoit E., Febrile diarrhea

Desgranges F., A train can hide another - Season 2

Chedid M., A typical sinus fungal infection in non immunocompromised 

diabetic patient

Brakhage A., Fungal immune evasion and host-pathogen interactions - new concepts for therapy

Wheeler R., Candida-innate immune interactions

Verweij P., Drug resistance and tolerance in fungi

Khanna N., New antifungal therapies on the horizon

Maini M. K., New insights into immunopathogenesis of hepatitis B

Urban S., Hepatitis D virus in 2023: virology, pathogenesis and new treatment approaches

Sáez-Cirión A., Reprogramming dysfunctional CD8+ T-cells in HIV infection

Schmeltz Søgaard O., The role of bNAbs in HIV curative strategies

Debyser Z., Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus

Berger Ch., Zinkernagel A., Invasive Group A Streptococcal infections, what's going on?

Hensley S. E., Multivalent mRNA-based influenza vaccines

Miller M. S., Respiratory mucosal delivery of next-generation COVID-19 vaccines

Karron R. A., Progress in RSV vaccines

Stocker R., Combining single-cell imaging and artificial intelligence for Antibiotic Susceptibility Testing in 90 minutes - slides not available

Kline K., Colonization, biofilm formation and virulence in Enterococcus faecalis

Henriques Normark B., Host-pathogen interaction in Streptococcus pneumoniae infections - slides not available

Miro J. M., Novel therapies of endocarditis

Burgener A.-V., Septic shock with severe thrombocytopenia in a pregnant woman

Ihle V., A case of disseminated nocardiosis after checkpoint inhibition

Colin-Benoit E., Febrile diarrhea

Desgranges F., A train can hide another - Season 2

Chedid M., A typical sinus fungal infection in non immunocompromised diabetic patient

Brakhage A., Fungal immune evasion and host-pathogen interactions - new concepts for therapy

Wheeler R., Candida-innate immune interactions

Verweij P., Drug resistance and tolerance in fungi

Khanna N., New antifungal therapies on the horizon

Maini M. K., New insights into immunopathogenesis of hepatitis B

Urban S., Hepatitis D virus in 2023: virology, pathogenesis and new treatment approaches

Sáez-Cirión A., Reprogramming dysfunctional CD8+ T-cells in HIV infection

Schmeltz Søgaard O., The role of bNAbs in HIV curative strategies

Debyser Z., Towards a Functional Cure of HIV-1: Insight Into the Chromatin Landscape of the Provirus

Berger Ch., Zinkernagel A., Invasive Group A Streptococcal infections, what's going on?

Andrew Chan; Neuroinflammation

Martin Beer; Fatal encephalitic borna disease virus 1 in solid-organ transplant recipients

Cédric Hirzel; Primer

Adolfo Garcia-Sastre; Universal influenza virus vaccines

Louis J. Bont; RSV immunization

Leonardo Visser; Yellow fever; vaccination; immunosuppressed patient

Genovefa Papanicolaou; How to treat CMV - New antiviral against CMV

Klara Posfay Barbe; Measles, varicella: vaccine benefit risk in immunocompromised patients

Clinical virology case presentations: Matthias von Rotz; Vanja Piezzi; Gaud Catho; Antonios Kritikos; Sara Burkhard; Pauline Vetter

Isabella Eckerle; The novel 2019 Coronavirus

Michael Huber; Primer

Ronald G. Collman; Metagenomic discovery of novel human viruses: The lung virome

Eddie Holmes; Evolution and emergence of infectious diseases, mechanisms by which RNA viruses jump species boundaries

Manuel Battegay, Jasmina Bogojeska; Primer

Alexandrea Calmy; ART: new challenges

Francis Barin; Role of neutralizing antibodies in mother-to-child transmission of HIV-1

Angela Ciuffi; HIV – single cell genomics

Christoph Fux; Primer

Beat Müllhaupt; Viral hepatitis B in the immunocompromised patient

Antonella Folgori; HCV vaccine developments: achievements and challenges

Silke Stertz; MHC class II proteins mediate cross-species entry of bat influenza viruses

Matthieu Perreau; Lymph node migratory dendritic cells modulate HIV-1 transcription through

PD-1 engagement

Caroline Tapparel; Modified Cyclodextrins as Broad-spectrum Antivirals

Santiago Gonzalez; Protection against influenza infection requires early recognition by

inflammatory dendritic cells

Ronald Dijkman; Characterization of emerging zoonotic viruses

Andrew Chan; Neuroinflammation

Martin Beer; Fatal encephalitic borna disease virus 1 in solid-organ transplant recipients

Cédric Hirzel; Primer

Adolfo Garcia-Sastre; Universal influenza virus vaccines

Louis J. Bont; RSV immunization

Leonardo Visser; Yellow fever; vaccination; immunosuppressed patient

Genovefa Papanicolaou; How to treat CMV - New antiviral against CMV

Klara Posfay Barbe; Measles, varicella: vaccine benefit risk in immunocompromised patients

Clinical virology case presentations: Matthias von Rotz; Vanja Piezzi; Gaud Catho; Antonios Kritikos; Sara Burkhard; Pauline Vetter - not available

Isabella Eckerle; The novel 2019 Coronavirus

Michael Huber; Primer

Ronald G. Collman; Metagenomic discovery of novel human viruses: The lung virome

Eddie Holmes; Evolution and emergence of infectious diseases, mechanisms by which RNA viruses jump species boundaries

Manuel Battegay, Jasmina Bogojeska; Primer - not available

Alexandrea Calmy; ART: new challenges

Francis Barin; Role of neutralizing antibodies in mother-to-child transmission of HIV-1

Angela Ciuffi; HIV – single cell genomics

Christoph Fux; Primer

Beat Müllhaupt; Viral hepatitis B in the immunocompromised patient

Antonella Folgori; HCV vaccine developments: achievements and challenges

Silke Stertz; MHC class II proteins mediate cross-species entry of bat influenza viruses

Matthieu Perreau; Lymph node migratory dendritic cells modulate HIV-1 transcription through PD-1 engagement

Caroline Tapparel; Modified Cyclodextrins as Broad-spectrum Antivirals

Santiago Gonzalez; Protection against influenza infection requires early recognition by inflammatory dendritic cells

Ronald Dijkman; Characterization of emerging zoonotic viruses

Oriol Manuel; Primer - EBV case….What to do?

Joshua Hill; The burden of DNA viruses in immunocompromised hosts

Feisal Khan; Epstein Barr Virus and PTLD after allogeneic HCT

Renata Stripecke; Validation of engineered immune cells against herpes viruses in humanized mice

Henning Olbrich; Validation of engineered immune cells against herpes viruses in humanized mice

Danielle Zerr; What is the clinical significance of HHV6 in the transplant setting

Marie Céline Zanella; Obese patient and flu

Stacey Schultz-Cherry; Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice

John V. Williams; Translational research on hMPV

Meno De Jong; Severe influenza

Sabine Kuster; Case presenter

Anna Hachfeld; Case presenter

Pauline Vetter; Case presenter

Dan Lebowitz; Case presenter

Fabian Tschumi; Case presenter

Fabien Zoulim; Aiming for cure in hepatitis B

Emily Blumberg; Use of HCV / HIV positive donors in organ transplantation

Jack T. Stapleton; Pegiviruses in humans

Benjamin Hampel; PrEP

Nichole Klatt; The role of the microbiome in drug metabolism and HIV infection

Alexandra Trkola; Imprinting broadly neutralizing antibody responses to HIV-1

Annelies Wilder-Smith; Dengue and Zika vaccine development

Jan Felix Drexler; Changing landscape of emerging arboviruses

Primer - EBV case….What to do? - Oriol Manuel

The burden of DNA viruses in immunocompromised hosts - Joshua Hill

Epstein Barr Virus and PTLD after allogeneic HCT - Feisal Khan

Validation of engineered immune cells against herpes viruses in humanized mice - Renata Stripecke, Henning Olbrich

What is the clinical significance of HHV6 in the transplant setting - Danielle Zerr

Obese patient and flu - Marie Céline Zanella

Severe Secondary Bacterial Infection in Influenza Virus-Infected Obese Mice - Stacey Schultz-Cherry

Translational research on hMPV - John V. Williams

Severe influenza - Meno De Jong

Case - Kuster Sabine
Case - Hachfeld Anna
Case - Vetter Pauline
Case - Lebowitz Dan
Case - Tschumi Fabian
Aiming for cure in hepatitis B - Fabien Zoulim

Use of HCV / HIV positive donors in organ transplantation - Emily Blumberg

Pegiviruses in humans - Jack T. Stapleton

Primer - PrEP - Benjamin Hampel

The role of the microbiome in drug metabolism and HIV infection - Nichole Klatt

Imprinting broadly neutralizing antibody responses to HIV-1 - Alexandra Trkola

Changing landscape of emerging arboviruses - Jan Felix Drexler

Dengue and Zika vaccine development - Annelies Wilder-Smith

Interactive session - Christoph Berger

Lukas Jeker: Genome engineering for Immunologic Reprogramming 

Genome engineering for Immunologic Reprogramming; Jeker Lukas 

The global dynamics of influenza viruses, Colin A. Russell

The Challenge of Hepatitis B in Asia, Henry L. Y. Chan

From Ebola vaccine candidates to immunization strategies, Claire-A. Siegrist

Zika: evolution of a public health emergency, Annelies Wilder-Smith

Virology of Zika and progress in vaccine development, Thomas P. Monath

Lassa: the forgotten hemorrhagic fever, Daniel G. Bausch 

Rapid response to viral outbreaks of concerns, Gary Kobinger

Four Decades of HIV-AIDS, Bernard Hirschel

Neuro-HIV: Key is treating the virus, Cavassini

Neuro-HIV: Key is understanding the brain, Du Pasquier

Neuro-HIV: Key is looking thoroughly at the brain, Granziera

Human genetics of infections, Bochud

Human genomics of infections, Fellay

Hepatitis E: the raw facts, Darius Moradpour

Management of Hepatitis C in 2017, Jean-Michel Pawlotsky (slide 23 updated)

Advances in antiretroviral therapy, José R. Arribas